10/21/2010

MiPod Nuclear has entered a licensing deal that gives Vector Trading exclusive rights to its patent-pending technology for the production of Mo-99 medical isotope. The agreement covers the use of the technology, which will employ depleted uranium in its procedure, in Australia and New Zealand.

Full Story:
Yahoo!

Related Summaries